≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Other endocrine disorders

DOID EFO Endpoint Browser PheWeb

E4_ENDODIS

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

557745

1. Apply sex-specific rule

None

557745

2. Check conditions

None

557745

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — E34, E35
  • Cause of death: ICD-10 — E34, E35

2 out of 7 registries used, show all original rules.

2220

4. Check minimum number of events

None

2220

5. Include endpoints

2346

6. Filter based on genotype QC (FinnGen only)

2100

Control definitions (FinnGen only)

Control exclude
E4_ENDOGLAND

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 31129 16403 14689
Only index persons 22605 12208 10397
Unadjusted period prevalence (%)
Whole population 0.44 0.47 0.41
Only index persons 0.42 0.45 0.40
Median age at first event (years)
Whole population 7.81 8.09 7.35
Only index persons 10.77 11.10 10.40

-FinnGen-

Key figures

All Female Male
Number of individuals 2100 1259 841
Unadjusted period prevalence (%) 0.42 0.45 0.39
Median age at first event (years) 16.66 16.73 16.57

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
2204
Matched controls
21100
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E34.39
ICD-10 Finland
Short stature, not elsewhere classified
666.9
307.7
302
5
E34.9
ICD-10 Finland
Endocrine disorder, unspecified
7508.9
307.7
592
*
H01AC01
ATC
somatropin; parenteral
593.8
307.7
320
6
E34.35
ICD-10 Finland
Abnormal growth retardation
903.2
307.7
510
7
E34.0
ICD-10 Finland
Carcinoid syndrome
+∞
307.7
319
*
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
21.5
307.7
387
207
E34.30
ICD-10 Finland
Short stature NOS
+∞
231.9
222
*
101
Kela drug reimbursment
Anterior pituitary hypofunction
+∞
212.8
204
*
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
46.3
173.6
106
23
E23.01
ICD-10 Finland
Isolated deficiency of growth hormone
+∞
165.2
159
*
H01CB02
ATC
octreotide; parenteral
390.3
151.6
153
*
130
Kela drug reimbursment
Malignant tumour
5.6
141.8
301
583
186
Kela drug reimbursment
Growth retardation associated with renal failure (growth hormone)
+∞
130.5
126
*
301
Kela drug reimbursment
Growth hormone
229.3
130.2
135
6
H02AB09
ATC
hydrocortisone; systemic
7.2
128.8
204
294
C17.9
ICD-10 Finland
Malignant neoplasm: Small intestine, unspecified
155.3
128.6
137
9
H01CB03
ATC
lanreotide; parenteral
327.2
127.7
130
*
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
38.3
126.8
81
21
E34.40
ICD-10 Finland
Constitutional tall stature
+∞
116.9
113
*
JFB00
NOMESCO Finland
Partial resection of small intestine
14.6
115.9
108
74
JN5ER
NOMESCO Finland
PET-CT of receptors in whole body
46.1
114.6
70
15
R62.8
ICD-10 Finland
Other lack of expected normal physiological development
15.4
110.4
100
65
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
10.3
108.7
127
125
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
9.2
106.7
135
148
JN7AQ
NOMESCO Finland
Somatostatin receptor SPET med low dose CT
520.2
103.8
104
*
E34.31
ICD-10 Finland
Short stature, prenatal disorder
1011.8
102.4
101
*
D77
ICPC
Malignant digestive neopl other/NOS
40.0
96.6
61
15
E34.45
ICD-10 Finland
Abnormal growth increase
200.4
95.5
100
5
XX7JT
NOMESCO Finland
Somatostatin isotope ablative therapy
927.9
94.1
93
*
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
4.7
93.7
234
516
L01AX03
ATC
temozolomide; systemic
20.0
91.8
73
36
D37.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Small intestine
29.5
82.8
57
19
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.4
80.6
217
507
JN4CD
NOMESCO Finland
Very extensive body CT
6.9
77.3
125
183
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
6.6
75.0
126
192
ZXE10
NOMESCO Finland
More than one and less than three hours
2.3
73.9
843
4449
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
17.4
73.2
62
35
ZXE00
NOMESCO Finland
One hour or less
2.2
71.3
1013
5831
E23.02
ICD-10 Finland
Neurosecretory dysfunction of the growth hormone
+∞
71.1
69
*
XX9AN
NOMESCO Finland
Complementary isotope examination or additional picture
96.7
70.0
78
8
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
5.3
69.6
148
283
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.5
65.1
251
754
602
Kela drug reimbursment
Children's severe malnutrition
6.4
64.6
112
176
H03AA01
ATC
levothyroxine sodium; systemic
2.5
63.6
515
2313
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
61.2
701
3650
25898
ICD-8 Finland
Polyglandular dysfunction and other diseases of endocrine glands, Alii definiti
+∞
60.7
59
*
A11CC03
ATC
alfacalcidol; systemic
6.7
60.7
99
146
C17.2
ICD-10 Finland
Malignant neoplasm: Ileum
152.6
58.1
62
*
E23.00
ICD-10 Finland
Panhypopituitarism
+∞
57.6
56
*
JN4BD
NOMESCO Finland
Extensive body CT
3.4
56.7
228
701
8240/3-C17.9
ICD-O-3
Neuroendocrine tumor, NOS, of small intestine, NOS
548.1
55.9
56
*
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
7.1
55.8
87
122
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.4
55.1
464
2107
JN4AD
NOMESCO Finland
Body CT examination
3.1
53.9
255
864
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.8
53.6
308
1161
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
265.8
52.5
54
*
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.6
52.4
186
527
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.2
52.3
554
2767
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
10.7
52.0
58
53
WX302
NOMESCO Finland
Thoracal epidural anesthesy
4.1
51.8
153
381
E34.3
ICD-10 Finland
Short stature, not elsewhere classified
+∞
51.4
50
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.0
51.1
243
825
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
5.5
51.0
102
184
Z31.5
ICD-10 Finland
Genetic counselling
3.1
50.6
235
787
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
50.4
973
6050
25899
ICD-8 Finland
Polyglandular dysfunction and other diseases of endocrine glands, Other and unspecified diseases of endocrine system
+∞
50.4
49
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
48.5
591
3108
E34.8
ICD-10 Finland
Other specified endocrine disorders
+∞
48.3
47
*
SPAT1262
SPAT
Handing over of treatment supplies
2.5
47.5
361
1556
XX3DW
NOMESCO Finland
Time consuming IT work
2.9
44.2
230
819
JN3AD
NOMESCO Finland
Abdominal CT examination
2.6
42.9
286
1156
E30.09
ICD-10 Finland
Delayed puberty NOS
407.5
41.6
42
*
A09AA02
ATC
multienzymes (lipase, protease etc.); oral
5.7
41.5
79
136
A12AA04
ATC
calcium carbonate; oral
7.8
40.8
58
73
E30.00
ICD-10 Finland
Familial delayed puberty
139.9
40.1
43
*
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.7
39.9
134
365
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
5.9
39.5
73
122
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
7.4
39.0
58
77
T73
ICPC
Neoplasm endocrine other/unspecified
194.9
38.3
40
*
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
5.3
38.2
79
147
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
3.8
37.4
119
312
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.0
37.1
526
2885
302
Kela drug reimbursment
Interferon alfa
+∞
37.0
36
*
UJF32
NOMESCO Finland
Coloscopy
2.0
37.0
470
2479
A04AA02
ATC
granisetron; systemic, transdermal
3.4
36.9
141
418
127
Kela drug reimbursment
Transplant complication
5.4
36.6
74
135
WX723
NOMESCO Finland
CPAP therapy
3.9
36.0
112
289
RD210, ,
NOMESCO Finland
3.6
35.5
123
342
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.8
34.6
856
5572
JFB30
NOMESCO Finland
Right hemicolectomy
7.9
34.5
48
59
XX2RW, ,
NOMESCO Finland
6.6
34.1
56
83
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.9
33.8
547
3123
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
3.1
33.7
147
472
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
5.8
33.6
63
107
JN7AN
NOMESCO Finland
Somatostatin receptor isotope imaging
327.8
33.4
34
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
33.3
885
5862
WVA30, ,
SPAT
2.9
33.0
160
546
A03FA01
ATC
metoclopramide; systemic, rectal
2.0
32.7
432
2300
121
Kela drug reimbursment
Severe hypofunction of sexual glands
6.1
32.3
57
91
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.4
32.0
246
1057
R62.0
ICD-10 Finland
Delayed milestone
3.5
31.8
112
315
ZXE20
NOMESCO Finland
More than three and less than five hours
2.2
31.7
305
1440
C10AC01
ATC
colestyramine; oral
4.4
31.6
82
185
JN4SR
NOMESCO Finland
Very extensive PET-CT of receptors in whole body
110.2
31.2
34
*
NH3EA
NOMESCO Finland
Feet X-ray examination with load
5.2
30.9
65
123
JKA20
NOMESCO Finland
Cholecystectomy
5.5
30.8
61
109
T99
ICPC
Endocr/metab/nutrit disease other
5.8
30.6
57
96
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
8.8
30.5
39
43
C17.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of small intestine
303.6
30.4
31
*
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.2
30.2
268
1223
H02AA02
ATC
fludrocortisone; oral
12.0
30.0
31
25
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.9
29.9
442
2437
JN7SN
NOMESCO Finland
Somatostatin receptor SPECT
+∞
29.8
29
*
ZXD05
NOMESCO Finland
Urgent procedure
1.8
29.4
626
3863
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.8
29.3
153
544
D35.0
ICD-10 Finland
Benign neoplasm: Adrenal gland
7.6
29.0
42
54
L01BC06
ATC
capecitabine; oral
3.9
29.0
87
219
E21.0
ICD-10 Finland
Primary hyperparathyroidism
48.6
28.8
35
7
105
Kela drug reimbursment
Adrenal cortical hypofunction
+∞
28.7
28
*
J01MA12
ATC
levofloxacin; systemic
2.1
28.7
309
1521
TPH07
NOMESCO Finland
Cathetrisation of artery
2.2
28.7
256
1170
E23.04
ICD-10 Finland
Hypogonadotropic hypogonadism
11.6
28.4
30
25
AAE10
NOMESCO Finland
Transsphenoidal total or partial excision of intracranial lesion
64.0
28.4
33
5
AA4CM
NOMESCO Finland
Extensive MRI examination of sella turcica with 3 Tesla magnet
283.0
28.3
29
*
XFE00
NOMESCO Finland
Epicardial ultrasonography
4.9
27.9
62
123
L03AB05
ATC
interferon alfa-2b; parenteral
37.8
27.5
35
9
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
6.2
27.5
48
76
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
6.2
27.5
48
76
L04AA06
ATC
mycophenolic acid; systemic
4.5
27.4
68
148
C25.4
ICD-10 Finland
Malignant neoplasm: Endocrine pancreas
272.8
27.3
28
*
C03CA01
ATC
furosemide; systemic
1.9
27.2
413
2291
BBA40
NOMESCO Finland
Subtotal parathyroidectomy
140.6
27.2
29
*
WX780
NOMESCO Finland
Remote monitoring CPAP
3.4
26.9
101
296
106
Kela drug reimbursment
Hypoparathyroidism
+∞
26.7
26
*
BF20A, ,
NOMESCO Finland
262.6
26.3
27
*
E83.50
ICD-10 Finland
Hypercalcemia
8.3
26.1
35
41
L04AA01
ATC
[U] ciclosporin
6.5
26.1
43
64
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
4.1
26.0
73
175
WZC00
NOMESCO Finland
Treatment plan or consultation
1.6
26.0
926
6505
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.0
25.9
342
1808
B03BA03
ATC
hydroxocobalamin; parenteral
3.3
25.9
101
303
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
4.7
25.7
61
128
N02AA05
ATC
oxycodone; systemic
2.1
25.6
275
1351
E22.1
ICD-10 Finland
Hyperprolactinaemia
38.8
25.3
32
8
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
3.9
25.2
76
192
OAB50, ,
SPAT
2.5
24.8
172
704
R4190
NOMESCO Finland
Nutritional therapy
2.2
24.3
216
984
E22.80
ICD-10 Finland
Central precocious puberty
242.2
24.3
25
*
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.1
24.1
246
1184
ZXD00
NOMESCO Finland
Emergency procedure
3.8
24.1
75
194
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
23.8
438
2568
8249/3-C17.9
ICD-O-3
Neuroendocrine tumor, grade 2 of small intestine, NOS
+∞
23.6
23
*
7834C
ICD-9 Finland
Symptoms concerning nutrition, metabolism and development, Lack of expected normal physiological development[HÄIRIINTYNYT PITUUSKASVU]
65.3
23.4
27
*
Z94.0
ICD-10 Finland
Kidney transplant status
5.3
23.2
47
86
104
Kela drug reimbursment
Thyroid insufficiency
2.7
23.2
129
474
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
4.8
22.9
52
105
Z51.5
ICD-10 Finland
Palliative care
2.5
22.2
140
547
Z51.80
ICD-10 Finland
Manipulation of puberty development with hormone therapy
116.1
22.2
24
*
-50
ICPC
Medication/prescr/renewal
3.2
22.2
90
277
SPAT1377
SPAT
Polysomnography
3.5
22.1
77
215
A79
ICPC
Malignancy NOS
5.5
22.0
43
76
A02BC01
ATC
omeprazole; systemic
1.7
22.0
489
3020
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
4.7
22.0
52
109
Z3226
NOMESCO Finland
Physiotherapist
1.7
21.6
429
2566
8240/3-C17.2
ICD-O-3
Neuroendocrine tumor, NOS, of ileum
60.5
21.4
25
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.3
21.3
180
802
JAH00
NOMESCO Finland
Laparotomy
3.5
21.2
74
207
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
5.0
21.1
46
90
F82
ICD-10 Finland
Specific developmental disorder of motor function
3.7
21.1
69
185
A41.9
ICD-10 Finland
Sepsis, unspecified
3.1
21.0
90
286
A55
ICPC
General and Unspecified, Local injection/infiltration
6.4
20.9
35
53
Z01.9
ICD-10 Finland
Special examination, unspecified
2.4
20.6
142
579
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.5
20.5
73
207
R50.9
ICD-10 Finland
Fever, unspecified
1.7
20.4
431
2617
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.0
20.3
228
1135
G02CB01
ATC
bromocriptine; systemic
5.1
20.3
43
82
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
202.9
20.2
21
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.3
20.1
169
751
Z2445
NOMESCO Finland
Psychologist
2.1
19.9
191
895
E28.2
ICD-10 Finland
Polycystic ovarian syndrome
5.7
19.7
37
63
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
19.7
737
5150
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
5.7
19.3
36
61
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
3.9
19.1
57
143
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.0
18.8
231
1185
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.8
18.6
348
2039
E30.1
ICD-10 Finland
Precocious puberty
53.1
18.6
22
*
E22.0
ICD-10 Finland
Acromegaly and pituitary gigantism
+∞
18.5
18
*
E34.1
ICD-10 Finland
Other hypersecretion of intestinal hormones
+∞
18.5
18
*
E34.5
ICD-10 Finland
Androgen resistance syndrome
+∞
18.5
18
*
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.9
18.4
261
1405
BCA31
NOMESCO Finland
Endoscopic unilateral adrenalectomy
26.9
18.3
25
9
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
5.9
18.3
33
54
E27.1
ICD-10 Finland
Primary adrenocortical insufficiency
183.4
18.2
19
*
XX9AD
NOMESCO Finland
Complementary CT
183.4
18.2
19
*
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
4.1
18.2
50
118
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
4.5
18.2
45
98
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
3.1
18.1
76
239
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
6.9
18.1
28
39
WX402
NOMESCO Finland
General anaesthesia
1.6
18.0
517
3384
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.6
18.0
458
2911
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.8
17.9
94
335
B03XA01
ATC
erythropoietin; parenteral
6.0
17.9
32
52
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.0
17.8
193
948
F59
ICD-10 Finland
Unspecified behavioural syndromes associated with physiological disturbances and physical factors
6.5
17.7
29
43
B81
ICPC
Anaemia vit B12/folate deficiency
3.2
17.6
69
208
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.4
17.5
122
500
102
Kela drug reimbursment
Diabetes insipidus
+∞
17.4
17
*
L04AX01
ATC
azathioprine; systemic
2.5
17.3
108
420
E29.1
ICD-10 Finland
Testicular hypofunction
7.2
17.3
26
35
E26.0
ICD-10 Finland
Primary hyperaldosteronism
91.7
17.2
19
*
JLC10
NOMESCO Finland
Distal pancreatectomy
35.4
17.2
22
6
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.1
17.0
174
836
RL140, ,
NOMESCO Finland
4.7
16.9
39
80
D76
ICPC
Malignant neoplasm pancreas
23.2
16.9
24
10
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.1
16.9
171
818
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
5.8
16.8
31
52
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
5.4
16.7
33
59
E21.3
ICD-10 Finland
Hyperparathyroidism, unspecified
30.4
16.7
22
7
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.6
16.6
499
3295
ZXA10
NOMESCO Finland
Bilateral
1.7
16.4
363
2221
8246/3-C17.9
ICD-O-3
Neuroendocrine carcinoma, NOS, of small intestine, NOS
+∞
16.4
16
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
16.4
443
2851
WZC30
NOMESCO Finland
Teaching
1.8
16.4
295
1706
N18.8
ICD-10 Finland
Other chronic renal failure
4.0
16.4
47
115
Z2446
NOMESCO Finland
Social worker
1.8
16.3
250
1377
XA800
NOMESCO Finland
Neuropsychological investigation
2.2
16.3
142
640
T10
ICPC
Growth delay
5.7
16.0
30
51
XF404
NOMESCO Finland
Ambulatory ECG
2.1
15.9
166
804
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.0
15.8
178
886
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
14.8
15.8
26
17
L04AD01
ATC
ciclosporin; systemic
3.3
15.7
60
178
UKC02
NOMESCO Finland
Cystoscopy
1.9
15.7
225
1213
N06AA09
ATC
amitriptyline; systemic
2.2
15.6
137
620
P05.1
ICD-10 Finland
Small for gestational age
5.7
15.6
29
49
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
15.5
482
3200
XKC03
NOMESCO Finland
Water cystometry
3.3
15.5
58
170
E28.3
ICD-10 Finland
Primary ovarian failure
57.9
15.5
18
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
2.7
15.4
83
300
R11
ICD-10 Finland
Nausea and vomiting
1.8
15.4
241
1337
C17.0
ICD-10 Finland
Malignant neoplasm: Duodenum
82.0
15.3
17
*
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
6.5
15.3
25
37
107
Kela drug reimbursment
Pernicious anaemia
4.8
15.2
34
68
340
Kela drug reimbursment
Everolimus
154.2
15.2
16
*
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
2.6
15.2
87
325
K06.18
ICD-10 Finland
Another gingival hyperplasia
5.4
15.1
30
54
205
Kela drug reimbursment
Chronic hypertension
1.7
15.1
310
1859
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.1
15.0
156
753
-44
ICPC
Preventive immunization/medic
2.1
14.8
153
738
158
Kela drug reimbursment
Everolimus
43.4
14.8
18
*
C03DA01
ATC
spironolactone; oral
1.9
14.7
186
963
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
5.8
14.7
27
45
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
2.9
14.6
71
243
UDC00
NOMESCO Finland
Ear microscopy
1.9
14.6
179
917
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
4.9
14.6
32
63
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.6
14.4
87
334
N04BC06
ATC
cabergoline; oral
17.7
14.3
22
12
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
4.6
14.2
34
72
SPAT1312
SPAT
General health counselling
1.4
14.2
780
5804
H05BX01
ATC
cinacalcet; oral
34.7
14.1
18
5
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
2.6
14.1
84
320
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.8
14.1
235
1327
L04AD02
ATC
tacrolimus; systemic
3.8
14.0
42
106
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.8
14.0
226
1264
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
4.4
14.0
35
77
137
Kela drug reimbursment
Uraemia requiring dialysis
5.0
14.0
30
58
TPH40
NOMESCO Finland
Insertion of a long peripheral venous catheter
5.7
13.9
26
44
C18.99
ICD-10 Finland
Malignant tumor in unspecified location in the colon other or unspecified histology
21.5
13.9
20
9
R5140
NOMESCO Finland
Monitoring the use of the aid
1.9
13.7
167
854
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.6
13.7
341
2145
K90.3
ICD-10 Finland
Pancreatic steatorrhoea
6.6
13.6
22
32
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
6.6
13.6
22
32
C18.09
ICD-10 Finland
Malignant tumor of caecum other or unspecified histology
28.9
13.6
18
6
JN4DD
NOMESCO Finland
Scout CT scan of torso
28.9
13.6
18
6
XF602
NOMESCO Finland
Bloodpressure monitoring
3.9
13.6
40
100
C17.1
ICD-10 Finland
Malignant neoplasm: Jejunum
51.4
13.5
16
*
KH1AD
NOMESCO Finland
CT of urinary organs
2.8
13.5
67
232
TK800
NOMESCO Finland
Hemodialysis
3.7
13.5
42
109
F83
ICD-10 Finland
Mixed specific developmental disorders
2.6
13.4
76
283
BB1BQ
NOMESCO Finland
Extensive scintigraphy of parathyroid gland, 2 isotopes, SPECT and low-dose CT
+∞
13.3
13
*
E23.6
ICD-10 Finland
Other disorders of pituitary gland
+∞
13.3
13
*
318
Kela drug reimbursment
Teriparatide
72.4
13.3
15
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.1
13.3
133
633
ZY010
NOMESCO Finland
Hospital outpatient
1.9
13.3
184
981
TPX10
NOMESCO Finland
Implantation of vascular injection port
2.8
13.1
67
236
Z96.6
ICD-10 Finland
Presence of orthopaedic joint implants
2.6
13.1
74
275
Z3231
NOMESCO Finland
Registered nurse
1.5
13.1
601
4311
321
Kela drug reimbursment
Paricalcitol and cinacalcet
24.8
13.1
18
7
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
3.2
13.1
51
154
YHMAS, ,
NOMESCO Finland
6.0
13.0
23
37
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.0
13.0
135
653
JAH01
NOMESCO Finland
Laparoscopy
2.4
12.9
92
381
XX4AW, ,
NOMESCO Finland
3.4
12.9
46
131
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
5.1
12.9
27
51
C18.19
ICD-10 Finland
Malignant tumor in appendix other or unspecified histology
38.5
12.9
16
*
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
2.7
12.9
68
244
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
3.7
12.8
41
109
J45.1
ICD-10 Finland
Nonallergic asthma
1.8
12.7
187
1017
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.7
12.7
70
257
SPAT1153
SPAT
Removal of sutures
1.5
12.7
476
3278
SPAT1325
SPAT
Vaccination
1.4
12.6
726
5419
Z50.0
ICD-10 Finland
Cardiac rehabilitation
6.1
12.5
22
35
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.6
12.5
306
1915
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.4
12.4
83
335
A12AA06
ATC
calcium lactate gluconate; oral
67.3
12.4
14
*
E30.9
ICD-10 Finland
Disorder of puberty, unspecified
67.3
12.4
14
*
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.7
12.4
240
1414
XX9TE
NOMESCO Finland
Compementary ultrasound examination
5.7
12.3
23
39
2592A
ICD-9 Finland
Other endocrine disorders, Carcinoid syndrome
+∞
12.3
12
*
2594A
ICD-9 Finland
Other endocrine disorders, Dwarfism, not elsewhere classified
+∞
12.3
12
*
8249/3-C25.9
ICD-O-3
Neuroendocrine tumor, grade 2 of pancreas, NOS
+∞
12.3
12
*
E25.01
ICD-10 Finland
Congenital adrenal hyperplasia
+∞
12.3
12
*
E27.5
ICD-10 Finland
Adrenomedullary hyperfunction
+∞
12.3
12
*
H05AA02
ATC
teriparatide; parenteral
+∞
12.3
12
*
WZA10
NOMESCO Finland
Extensive medical or dental certificate
3.6
12.3
41
112
E27.4
ICD-10 Finland
Other and unspecified adrenocortical insufficiency
125.2
12.2
13
*
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
3.3
12.2
46
136
H02AB06
ATC
prednisolone; systemic
1.4
12.1
794
6053
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
4.7
12.1
28
58
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
4.7
12.1
28
58
A06AD11
ATC
lactulose; oral
1.8
12.0
206
1171
D44.8
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement
36.1
12.0
15
*
E27.0
ICD-10 Finland
Other adrenocortical overactivity
36.1
12.0
15
*
G47.3
ICD-10 Finland
Sleep apnoea
1.6
11.9
327
2099
ZXH04
NOMESCO Finland
Procedure performed in other inpatient unit
5.7
11.9
22
37
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.9
11.9
145
742
A02BA02
ATC
ranitidine; systemic
1.7
11.9
244
1459
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
4.7
11.9
27
55
R68.8
ICD-10 Finland
Other specified general symptoms and signs
4.1
11.8
32
75
SPAT1281
SPAT
Other administrative function
1.8
11.8
184
1018
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
1.9
11.8
146
751
C25.2
ICD-10 Finland
Malignant neoplasm: Tail of pancreas
17.4
11.7
18
10
SPAT1260
SPAT
Consultation of another employee
1.6
11.6
336
2183
B01AB10
ATC
tinzaparin; parenteral
1.8
11.6
168
908
JF1BD
NOMESCO Finland
Very extensive small bowel CT
9.7
11.6
23
23
N06AX16
ATC
venlafaxine; oral
1.6
11.6
269
1658
EBA15
NOMESCO Finland
Extraction of multiple teeth
2.3
11.6
91
394
R4180
NOMESCO Finland
Podiatric therapy
4.4
11.6
29
64
C07AB02
ATC
metoprolol; systemic
1.6
11.6
254
1545
SPAT1301
SPAT
No procedures
1.4
11.5
617
4534
SPAT1249
SPAT
Treatment-related counselling outside office
1.4
11.5
810
6240
SPAT1263
SPAT
Sampling
1.4
11.4
847
6574
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.1
11.4
112
530
BCA30
NOMESCO Finland
Unilateral adrenalectomy
28.9
11.4
15
5
E23.2
ICD-10 Finland
Diabetes insipidus
62.5
11.4
13
*
R06.0
ICD-10 Finland
Dyspnoea
1.5
11.4
450
3123
FP4B5
NOMESCO Finland
ECG, prolonged recording (24 h)
3.4
11.4
41
118
WX400
NOMESCO Finland
Inhalation anesthesy
2.0
11.3
128
638
E30.8
ICD-10 Finland
Other disorders of puberty
+∞
11.3
11
*
E35.8
ICD-10 Finland
Disorders of other endocrine glands in diseases classified elsewhere
+∞
11.3
11
*
E24.0
ICD-10 Finland
Pituitary-dependent Cushing disease
+∞
11.3
11
*
E340, C179,
ICD-10 Finland
+∞
11.3
11
*
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
2.7
11.3
59
211
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.9
11.3
133
673
ZX120
NOMESCO Finland
Intravenous
1.8
11.3
174
960
8249/3-C17.2
ICD-O-3
Neuroendocrine tumor, grade 2 of ileum
115.5
11.2
12
*
E21.1
ICD-10 Finland
Secondary hyperparathyroidism, not elsewhere classified
115.5
11.2
12
*
Z49.1
ICD-10 Finland
Extracorporeal dialysis
4.5
11.1
27
58
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
5.2
11.1
23
43
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
3.9
11.1
32
79
K65.0
ICD-10 Finland
Acute peritonitis
4.9
11.0
24
47
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.6
11.0
291
1851
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.6
11.0
267
1665
E87.6
ICD-10 Finland
Hypokalaemia
2.6
11.0
61
225
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.2
10.9
94
424
N05BA04
ATC
oxazepam; oral
1.5
10.8
433
3010
B03XA02
ATC
darbepoetin alfa; parenteral
3.5
10.8
37
103
TJD20
NOMESCO Finland
Change of gastrostomy tube
4.2
10.7
28
64
KFH00
NOMESCO Finland
Operation for undescended or ectopic testis
4.3
10.7
27
60
Q87.19
ICD-10 Finland
Congenital malformation syndromes predominantly associated with short stature
41.7
10.7
13
*
KAC00
NOMESCO Finland
Nephrectomy
5.7
10.7
20
34
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
2.1
10.6
106
505
A02BC05
ATC
esomeprazole; systemic
1.4
10.6
613
4553
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
1.8
10.6
157
856
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.8
10.5
167
929
AA1AD
NOMESCO Finland
CT of head and brain
1.5
10.5
409
2828
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
1.7
10.4
197
1151
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.6
10.4
269
1701
E23.05
ICD-10 Finland
Lack of TSH
57.7
10.4
12
*
C08CA02
ATC
felodipine; oral
2.0
10.4
114
563
WZC15, ,
NOMESCO Finland
4.8
10.3
23
46
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
4.8
10.3
23
46
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.5
10.3
386
2645
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
10.3
384
2629
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.8
10.3
158
870
D64.9
ICD-10 Finland
Anaemia, unspecified
1.8
10.3
150
813
A50
ICPC
General and Unspecified, Medication/prescr/renewal
2.4
10.3
72
297
A06AH03
ATC
naloxegol; oral
4.2
10.3
27
62
E03
ICD-10 Finland
Other hypothyroidism
2.1
10.2
102
486
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
2.1
10.2
101
480
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
10.2
920
7329
F98.2
ICD-10 Finland
Feeding disorder of infancy and childhood
3.9
10.2
29
71
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
1.9
10.2
138
732
B01AB05
ATC
enoxaparin; parenteral
1.4
10.1
434
3054
WX110
NOMESCO Finland
Infiltration anesthesia
1.4
10.1
1559
13451
ZXF10
NOMESCO Finland
Interruption caused by technical failure of equipment
18.1
10.0
15
8
Z56.5
ICD-10 Finland
Uncongenial work
18.1
10.0
15
8
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
2.3
10.0
78
338
N91.0
ICD-10 Finland
Primary amenorrhoea
9.2
9.9
20
21
Q53.1
ICD-10 Finland
Undescended testicle, unilateral
4.0
9.9
28
68
K85
ICD-10 Finland
Acute pancreatitis
4.0
9.9
28
68
A07AA02
ATC
nystatin; oral
2.1
9.9
92
427
E0000UV, ,
ATC
1.3
9.9
901
7175
FM2CE, ,
NOMESCO Finland
2.1
9.9
89
408
V03AG01
ATC
sodium cellulose phosphate; systemic
4.8
9.9
22
44
ZYB02
NOMESCO Finland
Outreach service at unit of another specialty
3.6
9.9
32
86
N02AX02
ATC
tramadol; systemic, rectal
1.4
9.8
612
4593
BC00A, ,
NOMESCO Finland
10.8
9.8
18
16
8240/3-C34.9
ICD-O-3
Neuroendocrine tumor, NOS, of lung, NOS
38.4
9.8
12
*
OAB72
NOMESCO Finland
Weight control and weight loss guidance
3.9
9.7
28
69
IGY99
NOMESCO Finland
Other psychiatric treatment contact
1.9
9.7
117
597
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.6
9.7
54
200
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.0
9.7
111
557
L02AE02
ATC
leuprorelin; implant, parenteral
2.5
9.7
62
246
JFB20
NOMESCO Finland
Ileocaecal resection
5.4
9.6
19
34
WX610
NOMESCO Finland
Patient controlled analgesia
4.5
9.6
23
49
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
4.5
9.6
23
49
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.5
9.6
58
224
L01CB01
ATC
etoposide; systemic
7.8
9.5
21
26
WW500
NOMESCO Finland
Blood transfusion
2.2
9.5
82
370
L01BA01
ATC
methotrexate; systemic
2.4
9.5
62
248
Z99.2
ICD-10 Finland
Dependence on renal dialysis
9.2
9.5
19
20
A04AA01
ATC
ondansetron; systemic, rectal
1.8
9.5
152
849
L68.0
ICD-10 Finland
Hirsutism
4.8
9.4
21
42
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
2.9
9.4
43
143
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.1
9.4
83
378
XKD00
NOMESCO Finland
Uroflowmetry
1.7
9.3
188
1118
WF049
NOMESCO Finland
Radiotherapy of metastasis
2.6
9.3
52
193
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
2.5
9.3
55
210
-56
ICPC
Dressing/pressure/compress/tamponade
3.2
9.3
36
109
E23.03
ICD-10 Finland
Lack of ACTH
96.2
9.2
10
*
E21.2
ICD-10 Finland
Other hyperparathyroidism
96.2
9.2
10
*
BBA30
NOMESCO Finland
Excision of lesion of parathyroid gland
96.2
9.2
10
*
8240/3-C20.9
ICD-O-3
Neuroendocrine tumor, NOS, of rectum, NOS
96.2
9.2
10
*
SPAT1255
SPAT
Intravenous administration of medicine
2.0
9.2
96
465
2520A
ICD-9 Finland
Disorders of parathyroid gland, Hyperparathyroidism
+∞
9.2
9
*
E89.6
ICD-10 Finland
Postprocedural adrenocortical(-medullary) hypofunction
+∞
9.2
9
*
E24.9
ICD-10 Finland
Cushing syndrome, unspecified
+∞
9.2
9
*
L01EG02
ATC
everolimus; oral
+∞
9.2
9
*
E20.8
ICD-10 Finland
Other hypoparathyroidism
+∞
9.2
9
*
E20.1
ICD-10 Finland
Pseudohypoparathyroidism
+∞
9.2
9
*
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
2.4
9.2
60
240
X59
ICD-10 Finland
Exposure to unspecified factor
1.4
9.2
381
2659
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
2.4
9.2
63
258
197
Kela drug reimbursment
Sunitinib
16.8
9.2
14
8
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
1.8
9.2
142
785
Q87.14
ICD-10 Finland
Noonan's syndrome
20.9
9.1
13
6
H50.31
ICD-10 Finland
Intermittent exotropia
2.8
9.1
45
157
H02AB04
ATC
methylprednisolone; systemic
1.6
9.0
204
1249
SPAT1094
SPAT
Continuous Positive Airway Pressure
4.4
8.9
22
48
C18.90
ICD-10 Finland
Malignant tumor in unspecified location in the colon without histology
13.1
8.9
15
11
R55
ICD-10 Finland
Syncope and collapse
1.7
8.9
181
1078
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
7.0
8.9
21
29
-54
ICPC
Repair/fix-suture/cast/prosth device
3.0
8.9
39
127
KA1AE
NOMESCO Finland
Kidney ultrasound examination
2.7
8.9
47
170
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
1.9
8.8
116
609
T90
ICPC
Diabetes non-insulin dependent
1.5
8.8
293
1956
8240/3-C18.2
ICD-O-3
Neuroendocrine tumor, NOS, of ascending colon
35.3
8.8
11
*
Q87.88
ICD-10 Finland
Other specified congenital malformation syndromes, not elsewhere classified
7.4
8.8
20
26
SAA04
NOMESCO Finland
Special examination of mouth
1.7
8.8
170
1000
Q53.2
ICD-10 Finland
Undescended testicle, bilateral
8.0
8.8
19
23
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.6
8.8
186
1121
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
4.7
8.7
20
41
V03AE01
ATC
polystyrene sulfonate; oral
4.3
8.7
22
49
A11CC02
ATC
dihydrotachysterol; oral
23.1
8.7
12
5
S02.51
ICD-10 Finland
Fracture of tooth, open
1.7
8.7
157
907
K29.4
ICD-10 Finland
Chronic atrophic gastritis
3.4
8.7
31
89
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.5
8.7
52
200
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.3
8.7
65
277
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
2.2
8.7
74
333
SPAT1238
SPAT
Brief therapy
2.6
8.6
48
178
T29
ICPC
Endocr/metab/nutr sympt/compl other
3.1
8.6
36
114
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
1.8
8.6
128
699
SPAT1298
SPAT
Other function in accordance with nutritional therapy nomenclature
3.7
8.6
27
71
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.6
8.6
196
1203
SPAT1139
SPAT
Nutrition survey
2.3
8.6
62
260
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
8.6
660
5101
B05DB
ATC
Hypertonic solutions
4.8
8.5
19
38
JN5SR
NOMESCO Finland
Very extensive PET-CT of receptors in upper body
48.0
8.5
10
*
8240/3-C25.9
ICD-O-3
Neuroendocrine tumor, NOS, of pancreas, NOS
48.0
8.5
10
*
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
4.6
8.5
20
42
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
1.8
8.5
127
695
SPAT1324
SPAT
Screening procedure
0.5
8.4
96
1660
E05.0
ICD-10 Finland
Thyrotoxicosis with diffuse goitre
2.5
8.4
51
197
BA1AE
NOMESCO Finland
Thyroiid ultrasound examination
2.8
8.4
40
137
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.6
8.3
215
1358
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.7
8.3
157
917
H03BB01
ATC
carbimazole; oral
2.2
8.3
68
301
D44.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Endocrine gland, unspecified
26.4
8.3
11
*
D13.7
ICD-10 Finland
Benign neoplasm: Endocrine pancreas
26.4
8.3
11
*
8240/3-C16.9
ICD-O-3
Neuroendocrine tumor, NOS, of stomach, NOS
86.5
8.3
9
*
E20.9
ICD-10 Finland
Hypoparathyroidism, unspecified
86.5
8.3
9
*
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
3.1
8.2
33
102
E21.5
ICD-10 Finland
Disorder of parathyroid gland, unspecified
+∞
8.2
8
*
8249/3-C80.9
ICD-O-3
Neuroendocrine tumor, grade 2 of unknown primary site
+∞
8.2
8
*
E23.09
ICD-10 Finland
Pituitary insufficiency NOS
+∞
8.2
8
*
1CB02, ,
NOMESCO Finland
+∞
8.2
8
*
E20.0
ICD-10 Finland
Idiopathic hypoparathyroidism
+∞
8.2
8
*
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
2.3
8.1
61
260
E89.00
ICD-10 Finland
Postirradiation hypothyroidism
4.1
8.1
22
52
ED1AA
NOMESCO Finland
Mandibular X-ray examination
4.8
8.1
18
36
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
1.9
8.1
105
550
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.5
8.1
318
2195
B05DA
ATC
Isotonic solutions
4.2
8.1
21
48
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
8.2
8.0
17
20
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
2.2
8.0
67
299
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.5
8.0
221
1418
WX002
NOMESCO Finland
Sedation and analgesia
1.5
8.0
284
1921
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.3
8.0
1144
9599
E83.51
ICD-10 Finland
Hypocalcemia
6.8
8.0
19
27
N32.82
ICD-10 Finland
Instability of the detrusor vesicae muscle
3.5
8.0
27
75
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
3.7
7.9
25
66
ZX070
NOMESCO Finland
Intensity modified radiotherapy
3.4
7.9
28
80
D35.31
ICD-10 Finland
Cyst in Rathke's pocket
32.0
7.9
10
*
L01XE10
ATC
[U] everolimus
32.0
7.9
10
*
F81.8
ICD-10 Finland
Other developmental disorders of scholastic skills
3.3
7.9
29
85
SPAT1104
SPAT
Monitoring of emergency patient
1.9
7.9
105
555
SPAT1110
SPAT
Measurement of pain intensity
4.7
7.9
18
37
XLA10, ,
NOMESCO Finland
2.3
7.8
58
246
T81.2
ICD-10 Finland
Accidental puncture and laceration during a procedure, not elsewhere classified
4.5
7.8
19
41
A03FA02
ATC
cisapride; oral, rectal
1.8
7.8
107
570
XF600
NOMESCO Finland
Bloodpressure measurement
1.7
7.8
159
949
I31.3
ICD-10 Finland
Pericardial effusion (noninflammatory)
9.6
7.8
15
15
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
2.2
7.8
64
284
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
2.2
7.8
62
272
A10AE04
ATC
insulin glargine; parenteral
1.7
7.7
136
780
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
6.0
7.7
20
32
N91.4
ICD-10 Finland
Secondary oligomenorrhoea
6.0
7.7
20
32
J45.9
ICD-10 Finland
Asthma, unspecified
1.4
7.7
346
2446
5AB14, ,
NOMESCO Finland
6.9
7.7
18
25
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.6
7.7
169
1029
H52.0
ICD-10 Finland
Hypermetropia
2.1
7.7
74
350
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
2.4
7.6
49
195
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.6
7.6
159
954
H02AB02
ATC
dexamethasone; systemic
1.7
7.6
155
924
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.3
7.6
55
231
UJF92
NOMESCO Finland
Capsular endoscopy
2.3
7.6
55
231
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.1
7.6
68
312
JJA20
NOMESCO Finland
Open biopsy of liver
7.4
7.6
17
22
N06AB04
ATC
citalopram; systemic
1.5
7.6
289
1981
RL130, ,
NOMESCO Finland
3.2
7.6
30
92
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.6
7.6
173
1062
N05BA01
ATC
diazepam; systemic, rectal
1.6
7.6
190
1193
S55
ICPC
Skin, Local injection/infiltration
10.4
7.6
14
13
N06AX21
ATC
duloxetine; oral
1.6
7.6
188
1178
Y0099
ICD-8 Finland
Investigation of endocrine system and metabolism
9.0
7.5
15
16
H65.3
ICD-10 Finland
Chronic mucoid otitis media
1.7
7.5
126
713
HAHOM, ,
NOMESCO Finland
2.8
7.5
37
129
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
2.3
7.5
57
245
M81.9
ICD-10 Finland
Osteoporosis, unspecified
2.2
7.5
61
270
E86
ICD-10 Finland
Volume depletion
2.6
7.5
42
157
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.2
7.4
58
252
J01MA02
ATC
ciprofloxacin; systemic
1.3
7.4
532
4054
S50
ICPC
Skin, Medication/prescr/renewal
6.1
7.4
19
30
C74.9
ICD-10 Finland
Malignant neoplasm: Adrenal gland, unspecified
24.0
7.4
10
*
I15.8
ICD-10 Finland
Other secondary hypertension
4.4
7.4
18
39
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
3.3
7.4
27
79
JJB10
NOMESCO Finland
Atypcal resection of liver
11.4
7.4
13
11
SCA02
NOMESCO Finland
Preventive oral health care
1.4
7.3
442
3280
K92.1
ICD-10 Finland
Melaena
2.0
7.3
80
396
F50.1
ICD-10 Finland
Atypical anorexia nervosa
3.4
7.3
25
70
F50.0
ICD-10 Finland
Anorexia nervosa
2.9
7.3
34
115
E35.0
ICD-10 Finland
Disorders of thyroid gland in diseases classified elsewhere
76.9
7.3
8
*
8246/3-C80.9
ICD-O-3
Neuroendocrine carcinoma, NOS, of unknown primary site
76.9
7.3
8
*
E21
ICD-10 Finland
Hyperparathyroidism and other disorders of parathyroid gland
76.9
7.3
8
*
SPAT1310
SPAT
Counselling related to known health issue
1.3
7.3
631
4940
D13.6
ICD-10 Finland
Benign neoplasm: Pancreas
6.8
7.2
17
24
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
6.8
7.2
17
24
Z49.2
ICD-10 Finland
Other dialysis
4.2
7.2
19
44
XW000
NOMESCO Finland
Bone marrow biopsy
2.0
7.2
71
339
A02BC02
ATC
pantoprazole; systemic
1.3
7.2
1053
8815
E35.1
ICD-10 Finland
Disorders of adrenal glands in diseases classified elsewhere
+∞
7.2
7
*
E22.9
ICD-10 Finland
Hyperfunction of pituitary gland, unspecified
+∞
7.2
7
*
E23.1
ICD-10 Finland
Drug-induced hypopituitarism
+∞
7.2
7
*
E27.2
ICD-10 Finland
Addisonian crisis
+∞
7.2
7
*
E34.4
ICD-10 Finland
Constitutional tall stature
+∞
7.2
7
*
BB1AN
NOMESCO Finland
Parathyroid gland isotope imaging, 1 isotope
+∞
7.2
7
*
E23.08
ICD-10 Finland
Hypopituitarism
+∞
7.2
7
*
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
4.5
7.2
17
36
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
4.3
7.2
18
40
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.5
7.2
230
1524
WX204
NOMESCO Finland
Axillary plexus blockaced
2.3
7.1
53
226
A01AB09
ATC
miconazole; local oral
1.7
7.1
139
821
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.4
7.1
48
196
SPAT1317
SPAT
Planned health check-up monitoring, health check-up performed based on individual need
1.3
7.1
533
4088
TPX15
NOMESCO Finland
Removal of vascular injection port
6.6
7.0
17
25
M80.0
ICD-10 Finland
Postmenopausal osteoporosis with pathological fracture
2.9
7.0
31
102
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
4.1
7.0
19
45
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.8
7.0
102
555
ZX112
NOMESCO Finland
Subcutaneous
2.4
7.0
44
174
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
2.8
7.0
34
118
BAA40
NOMESCO Finland
Unilateral lobectomy of thyroid gland
2.8
7.0
34
118
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
3.3
7.0
26
77
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
3.2
7.0
27
82
E03.89
ICD-10 Finland
Other specified hypothyroidism
2.1
7.0
63
291
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
2.6
6.9
39
146
UJF12
NOMESCO Finland
Enteroscopy through intestinal stoma
11.5
6.9
12
10
AQ2
HP
Electrophysiological electroanatomical examination
11.5
6.9
12
10
F50.9
ICD-10 Finland
Eating disorder, unspecified
2.4
6.9
47
193
RT160, ,
NOMESCO Finland
3.3
6.9
25
73
J94.8
ICD-10 Finland
Other specified pleural conditions
3.6
6.9
22
59
TJF80
NOMESCO Finland
Ostomy education
3.2
6.8
26
78
R00.0
ICD-10 Finland
Tachycardia, unspecified
1.9
6.8
80
406
QXA20
NOMESCO Finland
Skin abrasion, unspecified location
9.6
6.8
13
13
SPAT1294
SPAT
Other function in accordance with health social work nomenclature
2.6
6.8
37
136
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
1.7
6.8
132
778
R63.8
ICD-10 Finland
Other symptoms and signs concerning food and fluid intake
5.8
6.8
18
30
K52.2
ICD-10 Finland
Allergic and dietetic gastroenteritis and colitis
2.2
6.8
55
243
M05BX04
ATC
denosumab; parenteral
2.0
6.8
70
340
R63.4
ICD-10 Finland
Abnormal weight loss
2.0
6.8
73
360
K03.66
ICD-10 Finland
Tooth plaque
1.5
6.8
231
1550
R03AC02
ATC
salbutamol; inhalant
1.3
6.8
1119
9478
SPAT1254
SPAT
Administration of medicine
1.4
6.8
327
2340
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
1.6
6.7
156
962
R4110
NOMESCO Finland
Physiotherapy
1.3
6.7
491
3746
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.2
6.7
57
257
K07.25
ICD-10 Finland
Anomalies of dental arch relationship
1.7
6.7
120
693
R53
ICD-10 Finland
Malaise and fatigue
1.3
6.7
471
3575
Q89.7
ICD-10 Finland
Multiple congenital malformations, not elsewhere classified
7.2
6.7
15
20
A12BA01
ATC
potassium chloride; oral
2.4
6.7
44
178
N20.9
ICD-10 Finland
Urinary calculus, unspecified
2.5
6.7
39
149
J21.0
ICD-10 Finland
Acute bronchiolitis due to respiratory syncytial virus
2.3
6.7
48
202
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
2.6
6.6
37
138
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
2.2
6.6
56
252
E26.9
ICD-10 Finland
Hyperaldosteronism, unspecified
38.4
6.6
8
*
C80.98
ICD-10 Finland
Malignant tumor without specified localization other specified histology
38.4
6.6
8
*
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.8
6.6
104
579
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
1.9
6.6
86
452
4AA09, ,
NOMESCO Finland
7.9
6.6
14
17
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
7.9
6.6
14
17
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
1.9
6.6
80
411
WX730
NOMESCO Finland
Conventional respirator
2.8
6.6
32
111
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
2.3
6.6
46
191
62
HP
Catheterization and pressure measurement of the right side of the heart
8.9
6.6
13
14
L03AA04, ,
ATC
16.0
6.6
10
6
T50
ICPC
Metabolic, Medication/prescr/renewal
16.0
6.6
10
6
WX882
NOMESCO Finland
High dependency care
1.7
6.6
115
660
C05AA08
ATC
fluocortolone; rectal, topical
1.6
6.6
160
999
SPAT1203
SPAT
Injection therapy, other than intramuscular or subcutaneous
2.2
6.5
50
216
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.4
6.5
260
1797
Z3229
NOMESCO Finland
Other healthcare associate professional
1.6
6.5
164
1032
RS220, ,
NOMESCO Finland
2.5
6.5
40
157
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.5
6.4
211
1405
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
2.0
6.4
70
347
N03AX16
ATC
[U] pregabalin
1.4
6.4
294
2084
C08CA01
ATC
amlodipine; oral
1.3
6.4
438
3308
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
7.5
6.4
14
18
H06.2*E05.9
ICD-10 Finland
Dysthyroid exophthalmos
7.5
6.4
14
18
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
2.0
6.4
68
334
ZYY98
NOMESCO Finland
Missed treatment contact, no notification given by patient
6.2
6.4
16
25
C02CA01
ATC
prazosin; oral
3.9
6.4
18
44
BC1AD
NOMESCO Finland
CT of adrenal glands
3.9
6.4
18
44
Z51.88
ICD-10 Finland
Other specified medical care
2.5
6.4
37
141
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
2.0
6.4
70
348
D37.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Colon
3.3
6.4
23
67
I15.9
ICD-10 Finland
Secondary hypertension, unspecified
3.6
6.3
20
53
K59.09
ICD-10 Finland
Constipation, unspecified
1.6
6.3
128
764
C26.0
ICD-10 Finland
Malignant neoplasm: Intestinal tract, part unspecified
67.1
6.3
7
*
1522B
ICD-9 Finland
Malignant neoplasm of small intestine, including duodenum, Ileum[NEOPLASMA MALIGNUM ILEI,ALIA DEFINITA SEU NUD]
67.1
6.3
7
*
H65.1
ICD-10 Finland
Other acute nonsuppurative otitis media
1.9
6.3
78
404
K80.5
ICD-10 Finland
Calculus of bile duct without cholangitis or cholecystitis
2.5
6.3
37
142
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
1.9
6.3
80
418
J05AB01
ATC
aciclovir; systemic
1.4
6.3
341
2486
K02
ICD-10 Finland
Dental caries
1.7
6.3
123
728
B01AA03
ATC
warfarin; systemic
1.5
6.3
190
1245
AA1BD
NOMESCO Finland
Extensive CT of head and brain
2.6
6.3
35
131
UJF30
NOMESCO Finland
Ileoscopy through colon
1.6
6.2
155
972
R03BA05
ATC
fluticasone; inhalant
1.3
6.2
390
2906
6BA02, ,
NOMESCO Finland
3.9
6.2
18
45
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.4
6.2
343
2509
J01FF01
ATC
clindamycin; systemic
1.3
6.2
393
2936
I20.99
ICD-10 Finland
Angina pectoris, unspecified
2.0
6.2
67
332
2533A
ICD-9 Finland
Disorders of the pituitary gland and its hypothalamic control, Pituitary dwarfism[NANISMUS HYPOPHYSARIUS]
+∞
6.1
6
*
E34.2
ICD-10 Finland
Ectopic hormone secretion, not elsewhere classified
+∞
6.1
6
*
E34
ICD-10 Finland
Other endocrine disorders
+∞
6.1
6
*
8240/3-C80.9
ICD-O-3
Neuroendocrine tumor, NOS, of unknown primary site
+∞
6.1
6
*
TAB24
NOMESCO Finland
Implantation of epidural injection gate
+∞
6.1
6
*
8246/3-C25.9
ICD-O-3
Neuroendocrine carcinoma, NOS, of pancreas, NOS
+∞
6.1
6
*
G03DC03
ATC
lynestrenol; oral
2.4
6.1
41
167
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.3
6.1
580
4576
M81.4
ICD-10 Finland
Drug-induced osteoporosis
7.8
6.1
13
16
XJC10
NOMESCO Finland
Oesophageal pH monitoring
3.4
6.1
21
59
120
Kela drug reimbursment
Hypogammaglobulinaemia
10.6
6.1
11
10
K80.0
ICD-10 Finland
Calculus of gallbladder with acute cholecystitis
2.1
6.1
52
235
N74
ICPC
Malignant neoplasm nervous system
17.3
6.1
9
5
Y28
ICPC
Limited function/disability (Y)
8.9
6.1
12
13
322
Kela drug reimbursment
Sunitinib
25.6
6.1
8
*
AA4DG
NOMESCO Finland
Very extensive MRI examination of sella turcica with high intensity magnet
25.6
6.1
8
*
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.4
6.1
338
2472
K56.7
ICD-10 Finland
Ileus, unspecified
3.0
6.1
26
84
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
4.2
6.1
16
37
JF1AD
NOMESCO Finland
Small bowel CT
4.2
6.1
16
37
E000003, ,
ATC
1.8
6.1
91
500
M01AE01
ATC
ibuprofen; systemic, rectal
0.8
6.1
1519
15576
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
2.4
6.1
40
162
R01AD08
ATC
fluticasone; nasal
1.3
6.1
462
3541
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
2.5
6.0
36
139
WX006
NOMESCO Finland
Intravenous sedation or analgesia without general anesthesia
1.8
6.0
90
494
WVA20
NOMESCO Finland
Medicine administration
2.1
6.0
56
262

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
465
1074
4.99
181.03
6.6
3.7
1.22
1.23
mmol/l
0.53
422
917
604
1820
4.00
165.07
3.2
2.1
317.45
373.42
nmol/l
7.76
581
1701
508
1466
4.01
145.95
4.6
3.6
—
—
—
0
0
333
772
4.69
126.71
2.4
1.6
6.68
7.07
u/l
0.22
213
541
184
297
6.38
103.97
4.5
4.8
2.64
2.17
mmol/l
1.13
142
177
635
2591
2.89
100.42
12.1
8.3
1.20
1.19
mmol/l
0.51
603
2451
1431
9040
2.47
86.61
21.1
11.2
0.00
0.00
e9/l
0.59
1227
7197
881
4494
2.46
86.33
6.6
3.7
7.39
7.39
ph
0.94
705
3137
335
1019
3.53
86.14
2.4
1.6
12.49
18.26
iu/l
3.20
230
781
185
360
5.28
85.61
4.2
4.1
—
—
—
0
0
972
5265
2.37
82.24
5.0
3.2
2.36
2.36
mmol/l
0.01
923
4828
140
254
5.57
69.78
5.3
4.7
11.05
6.82
pmol/l
0.98
140
254
379
1431
2.85
66.63
4.8
4.6
0.50
0.56
%
0.22
105
429
428
1766
2.64
63.08
3.4
3.3
0.21
0.21
g/l
0.37
403
1681
382
1492
2.76
62.72
5.2
4.9
0.72
0.89
%
0.54
107
447
371
1432
2.78
62.29
5.3
5.0
0.06
0.09
%
0.52
96
388
375
1463
2.75
61.64
5.3
5.2
0.31
0.10
%
0.44
93
364
1212
7782
2.09
61.12
14.2
8.7
1.22
1.22
mmol/l
4.06
1145
7292
309
1105
2.95
59.63
3.7
3.6
4.63
4.73
pmol/l
0.60
281
997
670
3472
2.22
58.76
3.9
2.9
524.65
552.68
mosm/kgh2o
2.21
611
3047
1282
8529
2.05
57.12
14.0
8.3
1.22
1.22
mmol/l
0.53
971
7573
519
2446
2.35
56.85
3.9
2.6
21.59
22.53
%
0.86
475
2307
1830
14058
2.45
54.89
6.6
4.1
14.87
14.58
pmol/l
5.09
1721
12946
1354
9342
2.00
52.52
11.5
7.7
3.01
2.94
%
0.45
1306
8832
1352
9328
2.00
52.38
11.6
7.8
0.66
0.66
%
0.12
1304
8829
1355
9367
2.00
52.06
11.5
7.8
8.82
8.56
%
2.78
1303
8863
570
2892
2.20
51.70
3.9
2.6
12.81
13.64
umol/l
1.94
527
2725
536
2665
2.22
51.03
3.9
2.6
2.46
2.43
g/l
0.49
495
2485
56
7
78.63
49.18
2.9
2.4
54.18
101.01
pmol/l
—
41
7
1378
9708
1.96
48.50
11.4
7.6
31.23
31.07
%
0.19
1335
9279
1070
6933
1.93
48.43
9.1
5.7
36.24
36.65
g/l
1.58
988
6543
273
1020
2.78
48.12
2.9
1.4
365.67
307.36
mu/l
1.48
246
915
1628
12177
2.07
47.96
13.3
7.4
100.01
88.05
u/l
10.63
1564
11554
188
570
3.36
47.64
3.4
2.8
55.33
55.59
%
0.09
188
570
316
1289
2.57
46.73
3.2
2.0
9.99
12.36
nmol/l
4.37
281
1161
688
3921
1.99
44.67
4.3
2.7
6.56
6.58
e6/l
0.01
634
3530
172
517
3.37
44.13
1.4
1.4
287.15
304.38
ug/g
0.46
112
286
543
2853
2.09
44.06
2.2
1.7
37471724.71
22594399.22
pmol/l
0.22
435
2421
304
1255
2.53
43.70
8.0
5.3
74.79
66.26
ng/l
0.74
255
1160
1487
10945
1.92
43.46
15.7
10.2
3.81
3.88
e9/l
0.62
1332
9309
305
1268
2.51
43.17
1.7
1.5
—
—
—
0
0
521
2718
2.09
42.95
10.7
6.1
0.81
0.82
mmol/l
1.25
494
2585
1165
7975
1.85
42.34
4.6
2.7
73.90
72.96
nmol/l
0.59
1102
7393
1382
9997
1.87
41.83
11.1
7.6
0.60
0.57
e9/l
4.09
1214
8449
1382
10003
1.87
41.68
11.2
7.6
0.04
0.04
e9/l
0.37
1213
8459
1329
9528
1.84
41.03
11.1
7.5
53.57
54.07
%
0.72
1307
9173
1410
10315
1.86
40.56
12.0
8.0
0.20
0.20
e9/l
0.83
1249
8892
711
4224
1.90
39.96
6.7
4.7
—
—
—
0
0
826
5160
1.85
39.57
4.7
3.0
0.01
0.06
estimate
0.73
434
1559
1397
10262
1.83
38.80
11.2
7.6
2.10
2.10
e9/l
0.03
1244
8930
809
5052
1.84
38.57
4.9
3.7
0.00
0.00
estimate
0.10
479
1814
818
5193
1.81
36.45
5.0
3.5
0.29
0.33
e6/l
0.35
666
3728
98
235
4.13
34.85
3.8
3.8
98.48
1365.90
u/ml
0.65
86
219
1158
8208
1.74
34.61
11.7
6.8
12.75
14.06
umol/l
0.96
1101
7749
777
4929
1.79
34.21
3.1
2.6
2.94
2.63
mg/l
3.17
692
4299
768
4907
1.76
32.64
3.7
2.7
58.21
75.61
u/l
0.53
708
4568
884
5879
1.73
32.60
1.7
1.6
0.94
2.23
u/ml
4.92
226
1378
942
6408
1.71
31.76
16.2
11.6
1.18
1.20
inr
0.40
840
5329
778
5058
1.73
30.66
5.1
3.4
2.00
1.97
estimate
—
5
13
1931
16215
2.13
30.17
7.2
5.0
1.79
1.88
mu/l
2.69
1827
15246
72
152
4.65
30.10
2.0
1.2
—
—
nmol/l
—
0
0
230
1016
2.30
27.95
21.9
13.8
1.40
1.14
mg/l
5.77
216
972
73
166
4.32
27.84
1.9
1.2
0.30
0.17
nmol/l
0.67
56
131
63
128
4.82
27.58
1.0
1.0
—
—
—
0
0
598
3701
1.75
27.51
4.6
3.9
910.31
1156.78
ng/l
1.47
501
3139
71
161
4.33
27.17
2.7
2.1
0.89
0.91
%
0.10
47
94
647
4133
1.71
26.36
6.6
4.1
—
—
—
0
0
855
5874
1.64
26.34
5.5
3.5
64.29
64.28
e6/l
0.00
694
4382
1333
10231
1.63
25.96
9.3
6.0
6.36
6.38
mmol/l
0.15
1285
9547
785
5343
1.63
24.70
1.9
1.6
1.98
2.00
g/l
0.12
430
3127
320
1693
1.95
24.10
1.4
1.4
—
—
—
0
0
459
2731
1.77
23.76
4.3
2.7
2.45
2.43
mmol/l
1.04
419
2426
1489
16302
0.61
23.58
25.9
17.3
333.21
333.59
g/l
0.89
1481
16194
301
1574
1.96
23.42
4.9
3.7
65.85
68.01
e9/l
0.49
204
1032
1719
14226
1.71
23.42
6.6
5.2
37.73
37.85
mmol/mol
0.22
1619
13439
1562
12618
1.64
23.30
6.1
4.3
10.92
9.88
mm/h
2.28
1461
11865
372
2102
1.84
22.79
6.0
4.3
1.57
1.62
%
0.53
336
1933
1895
16215
1.85
21.84
28.7
17.1
13.59
13.34
%
12.13
1878
16021
963
7030
1.55
21.69
6.5
4.2
71.61
87.29
e6/l
0.34
737
4637
952
6949
1.55
21.35
4.7
3.4
0.01
0.02
estimate
0.57
450
1598
105
364
2.85
21.04
1.9
1.4
0.30
0.37
nmol/l
0.72
80
291
70
193
3.55
20.50
4.4
4.2
24.64
25.47
umol/l
0.25
70
187
733
5090
1.57
20.26
4.5
3.4
34.19
60.39
ng/l
0.92
503
3118
310
1743
1.82
19.08
5.1
3.2
9.47
10.09
g/l
2.09
282
1636
126
505
2.47
18.96
2.1
1.9
6.76
2.17
ug/l
0.45
106
446
30
44
6.60
18.46
2.3
1.1
429.62
70.00
nmol/24h
0.50
30
44
69
202
3.34
18.45
1.4
1.3
1855.25
339.89
pmol/l
0.54
61
176
1246
9833
1.49
18.10
4.6
3.3
99.17
85.65
ug/l
1.60
1154
9284
58
157
3.61
17.49
2.7
2.1
—
—
—
0
0
357
2141
1.71
17.48
13.9
7.6
7.41
7.41
ph
0.03
310
1744
1220
9625
1.48
17.47
5.1
3.7
0.00
5.23
estimate
1.83
501
1925
82
278
2.89
17.15
4.5
3.0
72.23
68.53
%
1.01
82
272
811
5921
1.49
17.04
9.7
6.9
—
—
—
0
0
1208
9542
1.47
16.98
5.1
3.6
0.00
0.00
estimate
0.50
500
1931
86
304
2.78
16.66
4.6
3.0
1493.57
1451.17
e6/l
0.11
72
226
1220
9678
1.46
16.61
5.1
3.7
0.01
0.17
estimate
0.51
491
1857
198
1011
1.96
16.33
1.3
1.2
—
—
—
0
0
221
1179
1.88
15.98
3.8
4.4
9.37
21.12
ug/l
0.85
163
935
107
432
2.44
15.87
3.1
2.4
130.48
131.56
g/l
0.17
100
367
33
64
5.00
15.30
9.0
9.5
2.22
2.32
mg/l
0.10
28
54
644
4575
1.49
15.08
3.9
3.2
—
0.83
—
0
12
31
58
5.18
14.96
2.4
1.8
29.84
28.84
%
0.14
31
58
56
166
3.29
14.74
2.7
3.1
—
—
—
0
0
472
3159
1.55
14.58
3.0
3.0
101.33
108.24
ug/g
0.29
361
2560
246
1395
1.77
14.56
2.5
1.9
1.09
1.18
g/l
0.64
231
1309
339
2105
1.64
14.36
2.4
1.7
1548.86
1156.14
nmol/l
9.14
246
1591
831
6253
1.44
14.25
3.7
2.7
—
—
—
0
0
37
85
4.22
14.01
2.5
2.5
—
—
—
0
0
700
5118
1.45
13.93
3.4
2.8
—
—
—
0
0
48
134
3.48
13.87
1.3
1.1
113.69
114.41
pmol/l
0.03
48
134
33
70
4.57
13.80
2.4
3.0
15.11
17.08
%
1.91
33
70
329
2059
1.62
13.45
1.6
1.3
—
—
—
0
0
1411
11747
1.42
13.19
6.3
4.3
1104.50
1616.41
e6/l
0.22
24
150
21
32
6.33
12.47
1.2
1.3
—
—
—
0
0
80
320
2.45
12.16
3.9
2.3
73.97
70.82
mmol/l
0.22
67
271
50
156
3.12
12.15
1.5
1.7
—
—
—
0
0
633
4638
1.43
12.12
8.3
5.6
89.00
89.24
%
0.09
617
4558
31
70
4.29
12.03
1.5
2.2
20.25
19.50
nmol/l
—
8
20
32
75
4.13
11.84
1.2
1.3
—
—
—
0
0
26
54
4.65
11.17
1.5
1.3
0.00
0.06
estimate
0.49
26
54
350
2320
1.53
11.03
2.3
1.9
—
—
—
0
0
1254
10405
1.36
10.84
4.9
3.5
—
5942.41
—
0
17
495
3533
1.44
10.75
3.9
3.1
329.98
327.29
umol/l
0.20
447
3185
286
1826
1.57
10.64
21.5
9.5
7.80
7.12
mmol/l
1.22
280
1782
64
246
2.54
10.62
2.5
1.6
283.11
287.39
mosm/kgh2o
0.77
53
182
765
5923
1.36
10.18
4.5
3.7
30.28
31.61
u/l
0.76
719
5635
1445
12319
1.36
10.09
6.4
4.3
—
2.74
—
0
19
570
4219
1.40
9.98
1.8
1.6
20.74
19.93
nmol/l
0.59
484
3635
325
2170
1.51
9.84
2.9
2.9
4.43
4.74
e9/l
0.23
298
1921
29
73
3.84
9.79
2.8
2.6
530.30
511.43
min
0.39
23
53
338
2280
1.50
9.73
1.4
1.2
—
—
—
0
0
1926
17294
1.52
9.65
26.7
15.2
139.45
139.54
mmol/l
1.05
1889
16906
302
2007
1.51
9.33
1.3
1.2
—
—
—
0
0
1924
17308
1.51
9.16
27.1
15.3
3.94
3.94
mmol/l
0.02
1883
16871
27
68
3.84
9.12
2.6
3.1
1.14
1.11
umol/l
0.15
27
58
42
142
2.87
8.96
2.0
1.6
67.10
54.08
%
1.28
29
100
57
226
2.45
8.91
5.5
3.4
0.30
0.39
e9/l
0.64
37
128
59
239
2.40
8.81
1.4
1.3
—
—
—
0
0
24
57
4.06
8.77
1.7
1.7
1.05
0.90
iu/ml
0.26
14
32
268
1760
1.52
8.74
1.7
1.4
319.81
251.15
u/ml
0.60
247
1647
326
2234
1.47
8.62
2.1
1.6
—
—
—
0
0
59
242
2.37
8.58
1.3
1.3
2.45
2.49
g/l
0.06
36
193
59
242
2.37
8.58
1.3
1.3
0.36
0.38
g/l
0.20
36
191
59
242
2.37
8.58
1.3
1.3
6.99
6.44
g/l
0.57
36
194
79
367
2.10
8.53
2.3
1.9
—
—
—
0
0
79
367
2.10
8.53
2.3
1.9
—
—
—
0
0
705
5507
1.33
8.50
4.2
3.8
7.06
8.00
mmol/l
5.57
586
4840
29
81
3.46
8.47
3.8
3.6
—
—
—
0
0
54
215
2.44
8.39
3.0
4.2
—
—
—
0
0
63
269
2.28
8.37
5.4
3.2
175.19
203.06
e6/l
0.50
47
193
1999
18194
1.56
8.28
17.2
10.7
26.10
25.59
u/l
0.53
1951
17707
803
6410
1.31
8.25
2.3
1.9
1.37
1.30
mmol/l
1.54
602
5590
111
588
1.85
8.25
2.8
1.9
107.70
117.99
au/ml
0.33
37
194
2016
18391
1.58
8.18
20.9
11.3
—
—
—
0
0
114
611
1.83
8.16
2.7
1.9
—
—
—
0
0
78
367
2.07
8.16
2.3
1.9
—
—
—
0
0
78
367
2.07
8.16
2.3
1.9
—
—
—
0
0
33
103
3.10
8.10
2.1
1.6
28.78
38.95
%
0.77
23
70
32
99
3.13
7.98
3.8
1.9
—
—
—
0
0
502
3757
1.36
7.97
3.0
2.6
1.96
1.23
mg/l
0.88
373
2795
62
269
2.24
7.95
5.3
3.1
670.73
568.57
e6/l
0.59
45
188
2016
18408
1.57
7.94
27.0
15.5
71.21
69.45
umol/l
1.04
1992
18175
23
58
3.83
7.78
2.6
3.3
14.20
27.91
mg/l
—
10
27
30
91
3.19
7.73
2.7
2.6
720.65
605.19
ml
0.57
23
63
576
4436
1.33
7.49
2.6
2.3
153.54
252.90
u/l
3.51
535
4248
302
2097
1.44
7.41
2.0
1.5
—
—
—
0
0
44
169
2.52
7.41
5.6
8.1
1232.70
69.86
mg/mmol
0.50
38
158
303
2111
1.43
7.30
6.8
4.4
5.92
6.98
umol/l
0.78
236
1805
138
2066
0.62
7.06
1.6
1.7
3.40
3.41
ratio
0.03
96
1506
361
2615
1.38
6.94
1.7
1.4
459.20
498.36
titre
0.15
75
501
21
54
3.75
6.93
2.0
1.4
2.71
5.58
%
—
7
12
1349
11670
1.27
6.90
5.4
3.5
48.33
38.64
u/l
2.57
1272
11131
291
2035
1.43
6.86
15.0
7.4
23.38
23.74
mmol/l
1.62
291
2027
234
1574
1.47
6.77
1.2
1.2
—
35.15
—
0
10
154
947
1.60
6.72
5.5
5.1
22.23
21.80
s
0.38
142
881
173
1095
1.56
6.67
2.8
3.1
65.67
66.39
g/l
0.57
161
1022
320
2286
1.40
6.67
16.0
10.7
—
—
—
0
0
372
2746
1.36
6.33
4.7
3.9
30.43
29.99
s
0.98
359
2689
125
747
1.64
6.15
2.7
1.6
243.90
191.64
u/ml
1.17
79
378
161
1023
1.55
6.12
5.1
3.9
213.14
183.91
ng/l
0.24
150
922
64
313
1.99
6.11
3.4
3.6
1.44
3.50
ratio
1.04
20
178
31
112
2.67
5.94
3.7
3.1
815.87
889.10
u/ml
0.14
31
112
34
129
2.55
5.92
2.7
5.5
76.54
89.46
mg/l
0.49
28
117
48
213
2.18
5.92
1.7
1.4
5.51
8.95
u/ml
0.43
25
140
743
6078
1.26
5.78
2.2
2.0
—
—
—
0
0
346
2566
1.35
5.68
15.6
7.1
7.37
7.37
ph
0.24
254
1600
89
498
1.74
5.61
4.1
3.4
36.45
32.71
umol/l
0.91
83
458
106
1592
0.62
5.50
1.4
1.5
3.40
3.35
mmol/l
0.16
65
1052
519
4094
1.28
5.41
3.7
3.6
90.52
53.11
mg/l
0.43
320
2724
94
542
1.69
5.34
1.7
1.5
78.67
83.16
titre
0.12
15
57
124
1770
0.65
5.12
1.1
1.3
—
—
—
0
0
245
1750
1.38
5.10
16.2
7.8
—
—
—
0
0
66
348
1.84
5.10
3.6
3.8
34.72
50.32
mg/l
0.68
34
305
110
669
1.60
5.09
2.5
1.8
0.22
0.22
g/l
0.27
105
640
66
349
1.84
5.05
3.7
3.8
48.73
62.46
mg/l
0.35
34
306
86
492
1.70
5.04
1.8
1.4
8.39
3.77
ug/l
1.09
79
467
34
140
2.35
5.03
1.4
1.1
—
—
—
0
0
335
2520
1.32
4.97
15.7
7.1
0.86
1.36
mmol/l
1.45
266
2117
22
73
2.90
4.96
2.1
1.5
176.53
102.94
nmol/l
0.90
17
54
17
48
3.41
4.95
2.0
1.8
0.32
0.25
iu/ml
0.20
12
32
45
210
2.07
4.94
1.7
1.5
—
—
—
0
0
18
53
3.27
4.93
1.4
1.2
—
—
—
0
0
124
783
1.55
4.90
6.9
5.8
330.25
308.52
mg/l
0.11
100
479
22
75
2.83
4.74
1.1
1.4
129.64
141.73
nmol/l
0.62
22
75
110
686
1.56
4.61
2.5
1.8
1.15
1.17
g/l
0.21
104
655
102
625
1.59
4.60
2.5
2.1
1.31
1.41
g/l
0.49
83
559
338
2573
1.30
4.59
15.7
7.0
5.75
5.79
kpa
0.43
333
2513
50
251
1.93
4.52
4.0
3.6
0.83
1.35
%
0.95
50
230
2127
19912
1.65
4.50
34.0
20.4
89.00
89.21
fl
1.04
2111
19727
2127
19915
1.64
4.46
34.0
20.4
29.64
29.82
pg
4.29
2111
19729
2127
19916
1.64
4.44
34.0
20.4
4.49
4.54
e12/l
5.37
2086
19342
2127
19916
1.64
4.44
35.2
21.2
39.60
40.54
%
2.75
2109
19722
2126
19908
1.63
4.39
34.2
20.5
264.11
259.86
e9/l
1.96
2087
19392
193
1360
1.39
4.37
2.2
1.5
—
—
—
0
0
774
6509
1.21
4.37
2.0
2.0
94.59
96.29
pmol/l
0.47
440
3490
119
765
1.52
4.36
2.2
2.5
—
—
—
0
0
2127
19922
1.63
4.36
34.2
20.5
6.84
6.84
e9/l
0.03
2086
19347
2127
19922
1.63
4.36
34.5
20.7
132.01
134.62
g/l
13.75
2109
19740
20
68
2.83
4.35
1.1
1.3
141.85
151.64
mmol/24h
0.23
20
68
40
188
2.06
4.35
7.6
3.9
—
—
—
0
0
919
7862
1.20
4.32
4.1
3.3
6.17
6.27
ph
1.93
510
4174
12
23
5.02
4.28
7.0
6.7
37.00
19.29
ug/min
0.71
12
15
14
32
4.21
4.24
1.7
1.4
10.71
7.53
pmol/l
—
8
13
68
384
1.72
4.23
1.4
1.7
0.71
0.80
g/l
0.25
44
320
514
4159
1.24
4.20
5.3
4.3
45.15
8.65
mg/mmol
0.51
311
2698
390
3058
1.27
4.19
1.4
1.3
33.61
26.52
iu/ml
0.28
103
832
219
1588
1.36
4.17
1.4
1.3
114.10
153.91
u/ml
0.71
67
572
44
219
1.94
4.10
2.6
2.2
—
—
—
0
0
114
741
1.50
3.99
3.0
2.0
7.64
7.68
iu/ml
0.00
19
159
1951
18038
1.31
3.92
23.4
13.4
21.31
22.82
mg/l
1.29
1645
14234
7
7
9.60
3.90
1.7
1.4
449.57
1008.14
nmol/l
—
7
7
21
78
2.59
3.90
1.3
1.7
1.39
1.07
nmol/l
0.28
14
57
379
4337
0.80
3.68
4.2
3.5
1.02
1.02
kg/l
0.46
276
2846
19
70
2.61
3.60
2.9
1.8
—
—
—
0
0
78
480
1.58
3.53
2.0
3.8
31.09
3176.49
u/ml
0.88
64
411
80
496
1.56
3.51
2.5
2.9
—
—
—
0
0
85
535
1.54
3.49
1.6
1.4
—
1276.67
titre
—
0
9
20
77
2.50
3.48
2.5
3.9
98.86
138.44
ug/l
0.52
20
77
32
154
2.00
3.33
3.3
1.6
—
—
—
0
0
20
79
2.44
3.31
2.6
2.6
7.64
8.10
mmol/l
0.22
20
79
14
46
2.93
3.26
3.0
1.9
—
—
—
0
0
353
2818
1.24
3.23
1.4
1.3
5.73
10.10
u/ml
1.19
133
1043
68
415
1.59
3.22
1.2
1.2
13.95
181.70
iu/ml
4.89
22
118
231
1757
1.29
3.18
1.6
1.4
—
—
—
0
0
21
421
0.47
3.06
8.8
9.1
—
—
—
0
0
25
114
2.11
3.02
1.6
1.2
—
—
—
0
0
19
77
2.37
3.00
1.3
1.4
—
—
—
0
0
5
5
9.59
2.90
9.8
3.2
225.80
183.00
mg/l
—
5
5
218
1675
1.27
2.79
2.9
2.4
32.14
38.18
u/l
0.76
196
1390
49
287
1.65
2.77
1.1
1.1
1.47
1.45
g/l
0.11
49
267
25
119
2.02
2.73
1.4
1.4
—
—
—
0
0
22
100
2.12
2.70
4.1
3.9
1.88
3.29
%
—
8
38
93
633
1.42
2.67
1.2
1.2
—
—
—
0
0
40
225
1.71
2.64
1.5
1.3
—
—
—
0
0
28
141
1.91
2.62
3.7
1.7
24.10
6.59
ug/l
0.66
23
125
74
485
1.48
2.60
4.1
2.2
1.14
0.64
nmol/l
2.05
68
410
40
229
1.68
2.49
1.6
1.6
—
—
—
0
0
9
25
3.46
2.45
1.6
1.9
—
—
—
0
0
18
79
2.19
2.42
4.4
7.9
34.47
213.62
ug/l
—
8
55
22
105
2.02
2.41
4.0
2.1
1.53
1.94
u/field
0.31
17
64
40
232
1.66
2.39
4.6
4.1
—
—
—
0
0
7
16
4.20
2.38
1.0
1.2
—
—
—
0
0
6
12
4.80
2.31
1.0
1.0
—
22.40
—
0
5
11
38
2.78
2.28
1.4
1.2
—
—
—
0
0
8
22
3.49
2.26
5.9
2.9
4.80
4.55
mmol/l
—
8
22
33
185
1.72
2.24
1.2
1.1
—
—
—
0
0
14
57
2.36
2.23
1.3
1.4
7.42
7.36
ph
—
9
39
83
574
1.40
2.23
4.3
3.6
9.62
8.47
umol/l
0.29
71
462
18
336
0.51
2.21
2.3
3.8
4.00
3.87
mmol/l
0.52
18
331
76
519
1.42
2.20
2.6
2.8
12.30
13.59
e6/l
0.08
54
355
21
103
1.96
2.16
1.4
2.9
204.88
153.81
umol/l
—
8
58
76
525
1.40
2.08
2.7
2.9
453.64
8245.50
e6/l
0.49
58
376
90
640
1.36
2.07
1.4
1.3
—
—
—
0
0
76
526
1.40
2.06
2.5
2.7
3.58
3.52
mmol/l
0.22
69
502
87
616
1.37
2.05
1.1
1.1
0.77
0.61
u/ml
0.09
40
289
44
273
1.55
2.05
1.2
1.2
—
—
—
0
0
374
3135
1.17
2.04
5.2
3.3
3.89
2.66
e6/l
0.78
201
1538
20
100
1.92
1.97
1.7
1.3
82.65
74.28
umol/l
0.65
20
100
923
8243
1.12
1.97
3.9
3.0
—
—
estimate
—
0
0
25
136
1.77
1.91
1.2
1.1
—
—
—
0
0
24
129
1.79
1.91
1.0
1.1
—
—
—
0
0
38
233
1.57
1.88
1.2
1.4
42.28
40.23
u/l
0.04
33
204
90
651
1.34
1.88
1.1
1.1
10.06
9.33
u/ml
0.10
54
378
5
11
4.36
1.87
2.2
3.0
—
—
—
0
0
5
11
4.36
1.87
6.0
5.7
5.20
6.74
mmol/l
—
5
11
199
1592
1.22
1.84
9.9
10.8
7.41
7.41
ph
0.02
96
803
8
27
2.84
1.84
1.6
2.0
—
—
—
0
0
64
442
1.40
1.79
1.3
1.2
—
—
—
0
0
6
17
3.39
1.76
1.3
1.0
—
—
—
0
0
5
12
3.99
1.75
6.2
2.8
140.00
140.25
mmol/l
—
5
12
20
105
1.83
1.73
1.4
1.7
—
—
—
0
0
45
293
1.48
1.72
2.6
3.0
—
—
—
0
0
52
349
1.44
1.71
1.1
1.1
—
—
—
0
0
7
23
2.92
1.71
1.3
1.0
—
—
—
0
0
1618
14988
1.13
1.70
5.1
4.1
5.73
5.72
mmol/l
0.24
1490
13868
197
1590
1.20
1.68
9.9
10.8
13.37
13.22
kpa
0.13
191
1539
197
1590
1.20
1.68
10.0
10.8
5.18
5.14
kpa
0.22
191
1538
16
79
1.95
1.66
1.9
1.2
—
—
—
0
0
16
79
1.95
1.66
1.9
1.2
—
—
—
0
0
16
79
1.95
1.66
1.9
1.2
—
—
—
0
0
179
1434
1.21
1.66
10.4
11.4
94.53
95.60
%
0.81
173
1389
195
1576
1.20
1.65
9.9
10.9
0.09
0.59
mmol/l
0.85
164
1302
5
13
3.69
1.65
2.2
3.2
—
—
—
0
0
33
203
1.56
1.64
1.0
1.1
—
—
—
0
0
57
747
0.72
1.64
1.8
1.8
—
—
—
0
0
7
24
2.80
1.63
1.3
1.1
—
—
—
0
0
26
151
1.66
1.62
1.5
1.3
—
—
—
0
0
37
235
1.52
1.61
1.5
1.3
—
60.95
—
0
11
13
60
2.08
1.60
1.5
1.2
—
—
—
0
0
50
666
0.71
1.59
1.1
1.1
0.54
0.64
ratio
—
5
66
75
938
0.76
1.59
20.7
6.7
1.04
1.21
%
2.08
75
933
123
953
1.25
1.57
1.2
1.2
5.10
6.29
u/ml
0.42
82
667
30
184
1.57
1.53
3.0
4.4
67.75
74.62
u/ml
0.07
13
55
75
549
1.32
1.50
2.4
2.5
214.79
422.51
ug/l
1.33
67
519
47
319
1.42
1.49
1.4
1.4
2.32
4.01
u/ml
2.22
25
157
517
4531
1.12
1.47
1.9
1.8
—
—
—
0
0
100
763
1.27
1.47
1.3
1.2
—
—
—
0
0
10
43
2.23
1.46
1.0
1.3
—
—
—
0
0
91
688
1.28
1.44
1.1
1.1
7.69
6.71
u/ml
0.15
59
422
6
21
2.74
1.43
1.2
1.4
63.83
71.95
ug/l
—
6
21
190
1555
1.19
1.43
2.7
2.4
9705.36
7548.56
u/l
0.23
63
607
26
157
1.59
1.42
2.0
2.4
0.75
1.45
g/24h
1.36
18
99
119
932
1.24
1.40
1.2
1.2
1.85
1.09
u/ml
0.30
71
586
9
38
2.27
1.40
2.0
2.3
—
—
—
0
0
43
291
1.42
1.40
3.8
2.5
76.04
78.37
ug/min
0.02
29
187
13
64
1.95
1.38
2.5
1.8
119.31
88.94
ng/l
0.41
13
64
84
635
1.28
1.35
1.1
1.1
0.87
9.65
eliau/ml
—
6
97
59
425
1.34
1.34
1.4
1.2
18.88
48.20
u/ml
—
5
31
238
1996
1.16
1.34
1.8
1.9
—
—
—
0
0
30
191
1.51
1.33
1.6
1.2
—
—
—
0
0
47
327
1.38
1.32
1.2
1.2
—
—
—
0
0
130
1038
1.21
1.29
1.2
1.2
2.64
3.00
u/ml
0.13
84
687
25
154
1.56
1.28
1.2
1.1
—
—
—
0
0
51
362
1.36
1.28
1.5
1.3
—
—
—
0
0
15
80
1.80
1.28
1.1
1.3
—
—
—
0
0
331
2850
1.13
1.27
1.8
1.6
—
—
—
0
0
5
18
2.66
1.22
1.0
1.3
—
—
—
0
0
39
267
1.41
1.22
1.7
1.4
354.03
357.59
mu/l
0.03
33
206
73
551
1.28
1.21
2.1
2.2
2.06
13.59
iu/l
0.62
32
238
116
923
1.21
1.21
1.1
1.2
2.79
2.92
u/ml
0.05
77
621
6
25
2.30
1.17
4.5
4.6
3.07
3.68
mg/l
—
6
25
30
197
1.46
1.17
1.6
1.2
—
—
—
0
0
0
33
0.00
1.16
0.0
1.2
—
137.92
—
0
26
11
55
1.92
1.14
6.9
7.3
—
—
—
0
0
28
183
1.47
1.13
1.1
1.1
—
—
—
0
0
96
1108
0.82
1.10
1.7
1.6
71.31
58.27
ug/l
1.66
82
963
8
39
1.97
1.09
2.6
1.5
—
—
—
0
0
5
20
2.40
1.09
3.4
1.6
—
—
—
0
0
72
853
0.80
1.07
1.8
1.6
—
—
—
0
0
143
1179
1.17
1.04
1.2
1.2
—
—
—
0
0
34
235
1.39
1.04
2.6
2.5
—
—
—
0
0
28
187
1.44
1.03
1.1
1.2
39.44
33.93
mg/l
0.33
18
150
98
782
1.21
1.03
2.0
2.0
0.00
0.00
estimate
0.50
40
271
55
411
1.29
1.02
3.0
2.7
—
—
—
0
0
88
696
1.22
1.01
2.5
2.4
—
—
—
0
0
51
378
1.30
1.01
1.9
2.3
9.48
11.41
mg/l
0.67
44
356
20
125
1.54
1.00
1.0
1.1
1111.50
1529.26
miu/ml
1.02
20
125
72
841
0.81
0.96
1.7
1.5
—
—
—
0
0
7
35
1.92
0.95
2.1
2.1
0.63
0.61
mmol/l
—
7
35
24
159
1.45
0.93
3.3
4.9
0.79
0.76
index
0.05
24
159
24
324
0.71
0.92
1.9
1.9
—
—
—
0
0
10
164
0.58
0.92
1.8
1.6
—
—
—
0
0
11
60
1.76
0.91
1.1
1.1
—
—
—
0
0
45
334
1.30
0.90
1.1
1.1
2.91
6.49
iu/ml
—
10
64
15
221
0.65
0.90
1.1
1.4
—
183.33
—
0
9
642
5822
1.08
0.88
3.8
2.6
—
—
—
0
0
51
387
1.27
0.87
1.5
1.7
—
17.43
—
0
7
23
154
1.43
0.86
1.0
1.0
—
—
—
0
0
52
397
1.26
0.85
1.1
1.1
0.72
3.95
eliau/ml
2.67
13
161
1596
15588
0.93
0.84
5.2
4.7
2.63
2.70
mmol/l
2.61
1474
14661
1477
14455
0.93
0.80
4.2
3.7
1.29
1.20
mmol/l
4.19
1348
13519
0
25
0.00
0.78
0.0
1.0
—
78.08
—
0
25
72
820
0.84
0.78
1.7
1.5
1.22
1.27
mm
0.48
56
613
109
905
1.16
0.78
1.9
1.6
0.26
0.28
mg/l
0.15
47
399
6
32
1.80
0.78
1.5
1.1
—
—
—
0
0
146
1240
1.14
0.76
4.8
3.8
7.38
7.34
ph
3.84
121
881
18
118
1.46
0.76
1.3
1.4
—
—
—
0
0
446
4536
0.93
0.75
3.9
2.6
—
—
—
0
0
91
1011
0.86
0.75
2.2
2.3
5.72
7.65
ug/l
0.88
79
896
276
2853
0.92
0.69
3.3
3.8
396.08
577.57
ng/l
0.72
175
1962
51
400
1.23
0.69
1.2
1.2
—
—
—
0
0
1577
15368
0.94
0.68
4.9
4.2
1.42
1.45
mmol/l
1.98
1452
14445
7
112
0.60
0.68
3.0
2.3
—
—
—
0
0
366
3284
1.08
0.68
5.1
3.1
0.78
1.05
e6/l
0.84
198
1687
556
5588
0.94
0.67
4.0
2.8
0.00
0.04
—
6
71
7
41
1.64
0.67
1.1
1.1
—
—
—
0
0
7
41
1.64
0.67
1.1
1.1
—
—
—
0
0
7
41
1.64
0.67
1.1
1.1
—
—
—
0
0
5
27
1.77
0.65
1.8
1.3
—
—
—
0
0
20
139
1.38
0.65
1.3
1.2
—
—
—
0
0
28
206
1.31
0.64
3.5
3.5
0.90
0.81
nmol/l
0.39
21
176
172
1809
0.90
0.63
3.6
3.1
0.78
0.76
ug/l
0.13
123
1102
5
28
1.71
0.63
2.8
1.2
—
—
—
0
0
615
5635
1.06
0.63
2.3
2.2
—
—
—
0
0
162
1704
0.90
0.60
2.0
2.0
—
—
—
0
0
1593
15487
0.94
0.57
5.0
4.3
4.47
4.56
mmol/l
3.27
1467
14647
6
34
1.69
0.57
1.7
1.6
—
—
—
0
0
25
185
1.30
0.57
1.9
2.3
—
—
—
0
0
69
571
1.16
0.56
1.4
1.2
—
—
—
0
0
14
187
0.71
0.56
1.4
1.6
0.56
0.50
e9/l
0.29
14
187
165
1725
0.91
0.56
2.0
2.1
—
—
—
0
0
48
385
1.20
0.56
4.3
7.0
1.23
1.27
mmol/l
0.15
39
336
165
1722
0.91
0.54
2.0
2.1
—
—
—
0
0
164
1712
0.91
0.54
2.0
2.1
—
—
—
0
0
69
574
1.16
0.53
1.4
1.2
—
—
—
0
0
49
551
0.85
0.51
1.4
1.2
—
—
—
0
0
85
917
0.88
0.51
1.5
1.6
—
—
—
0
0
136
1428
0.91
0.51
2.8
2.3
6.17
6.19
ph
0.08
89
949
24
180
1.28
0.51
1.1
1.1
188.06
218.29
mg/l
0.55
18
157
198
2040
0.92
0.50
1.7
1.6
1143.96
968.59
mu/l
1.37
171
1798
7
45
1.49
0.47
1.1
1.4
9.26
9.89
mmol/l
—
7
45
31
243
1.22
0.47
1.5
1.3
9.38
17.72
u/l
2.22
25
209
30
349
0.82
0.46
2.0
1.6
7732.65
16034.74
e6/l
1.33
20
249
7
47
1.43
0.46
3.3
2.3
—
—
—
0
0
12
82
1.40
0.45
7.3
4.5
5.14
4.91
kpa
0.55
12
82
23
176
1.25
0.43
1.3
1.2
—
—
—
0
0
21
159
1.27
0.43
1.5
1.2
0.56
0.56
ratio
—
5
84
386
3861
0.95
0.42
2.0
1.9
—
—
—
0
0
124
1291
0.91
0.42
1.5
1.5
—
—
—
0
0
0
15
0.00
0.41
0.0
1.0
—
26.49
—
0
9
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
136
1203
1.09
0.40
2.7
2.7
—
—
—
0
0
12
84
1.37
0.40
2.2
2.6
14.26
18.08
umol/l
0.61
12
84
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
16
118
1.30
0.40
1.3
1.4
541.40
43391.78
e6/l
—
5
65
19
144
1.27
0.39
1.0
1.1
—
—
—
0
0
29
232
1.20
0.38
1.1
1.3
1.71
17.66
u/ml
0.90
19
182
154
1580
0.93
0.38
2.1
2.0
0.07
0.02
estimate
0.31
45
356
71
611
1.12
0.37
1.2
1.1
14.00
18.54
au/ml
—
5
108
13
94
1.33
0.37
1.2
1.2
177.52
186.97
pmol/l
0.10
13
94
10
69
1.39
0.36
1.0
1.4
26.20
28.01
s
—
10
69
5
74
0.65
0.35
6.8
5.4
8.60
7.99
%
—
5
74
5
74
0.65
0.35
3.4
2.7
44.80
44.61
%
—
5
74
157
1604
0.93
0.35
2.0
2.1
—
—
—
0
0
25
286
0.83
0.35
1.1
1.2
—
—
—
0
0
9
119
0.72
0.35
1.1
1.2
—
1.87
nmol/l
—
0
16
27
306
0.84
0.35
1.3
1.7
—
2088.00
—
0
10
59
506
1.12
0.34
2.9
3.5
5.56
4.41
index
0.25
41
286
6
44
1.31
0.33
1.5
2.0
—
—
—
0
0
11
137
0.77
0.32
1.5
2.7
106.73
105.49
mmol/l
0.55
11
137
42
354
1.14
0.32
1.3
1.4
8.86
2.80
u/ml
1.13
24
223
76
665
1.10
0.31
1.5
1.6
5.16
9.54
u/ml
1.08
14
143
7
94
0.71
0.31
1.0
1.1
—
—
—
0
0
644
6313
0.97
0.29
1.9
1.7
—
—
—
0
0
198
1804
1.06
0.29
1.6
1.5
—
—
—
0
0
13
98
1.27
0.29
1.0
1.1
—
—
—
0
0
13
98
1.27
0.29
1.0
1.0
—
—
—
0
0
86
761
1.09
0.29
2.5
2.8
—
—
—
0
0
91
810
1.08
0.27
1.5
1.3
—
—
—
0
0
54
471
1.10
0.25
1.1
1.2
—
—
—
0
0
9
71
1.21
0.25
1.0
1.0
—
—
—
0
0
17
136
1.20
0.24
1.4
1.4
805.71
2262.08
e6/l
—
7
91
11
131
0.80
0.24
1.5
2.7
1.21
1.19
mmol/l
0.41
11
131
13
102
1.22
0.22
1.1
1.1
142.07
221.04
iu/ml
1.11
13
102
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
8
97
0.79
0.21
6.5
3.5
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
13
0.00
0.20
0.0
1.1
—
7.03
—
0
8
20
166
1.15
0.20
2.1
2.5
1.56
1.96
mmol/l
0.28
11
133
41
358
1.10
0.20
1.0
1.0
10.59
8.45
mu/l
0.55
34
310
138
1382
0.95
0.20
2.0
2.2
—
—
—
0
0
12
138
0.83
0.20
1.4
2.7
4.24
3.99
mmol/l
0.60
12
138
7
55
1.22
0.18
2.1
1.6
—
—
—
0
0
7
58
1.16
0.17
1.3
1.1
—
—
—
0
0
5
63
0.76
0.17
2.2
1.4
—
—
—
0
0
5
64
0.75
0.17
2.8
1.7
—
—
—
0
0
8
65
1.18
0.16
1.1
1.1
—
—
—
0
0
22
189
1.12
0.15
1.8
2.3
2.94
4.18
u/ml
—
9
71
9
79
1.09
0.14
3.9
2.8
—
—
—
0
0
32
282
1.09
0.14
1.0
1.0
3.17
3.29
kpa
0.23
26
236
11
123
0.86
0.14
2.2
2.6
—
—
—
0
0
123
1136
1.04
0.13
1.8
2.0
—
—
—
0
0
8
95
0.81
0.13
1.0
1.2
3.34
3.81
u/ml
—
8
79
13
108
1.15
0.13
1.1
1.2
—
47.25
—
0
13
78
780
0.96
0.12
3.3
2.9
1.02
1.02
ratio
0.76
66
696
21
182
1.11
0.12
1.2
1.3
—
—
—
0
0
32
284
1.08
0.12
1.0
1.0
-0.69
-1.97
mmol/l
—
7
64
32
284
1.08
0.12
1.0
1.0
—
—
—
0
0
32
284
1.08
0.12
1.0
1.0
7.62
7.16
kpa
0.76
26
238
32
329
0.93
0.12
4.4
3.2
32.45
24.85
mg/l
0.62
26
221
139
1292
1.03
0.11
2.4
2.4
14.48
18.23
au/ml
0.31
14
137
24
211
1.09
0.11
1.5
1.5
6.94
7.78
mmol/l
0.55
24
206
130
1209
1.03
0.11
5.2
2.4
0.20
0.41
e6/l
1.12
125
1156
323
3042
1.02
0.10
5.2
5.1
1.69
2.59
ug/l
1.95
281
2732
73
727
0.96
0.10
1.1
1.1
—
—
—
0
0
93
861
1.04
0.10
1.1
1.1
—
—
—
0
0
17
179
0.91
0.10
2.0
2.1
19.22
28.93
mg/l
—
9
112
128
1193
1.03
0.09
1.3
1.3
36.33
43.06
au/ml
—
8
67
104
966
1.03
0.09
14.9
13.8
0.61
0.66
%
0.63
104
961
36
325
1.06
0.09
1.1
1.1
—
—
—
0
0
38
344
1.06
0.09
1.3
1.5
6.63
14.41
u/ml
0.53
17
194
5
58
0.82
0.08
1.0
1.2
—
—
—
0
0
100
980
0.98
0.06
1.3
1.3
225.44
236.61
miu/ml
0.11
45
486
9
96
0.90
0.06
1.0
1.3
7.56
8.63
mm/h
—
9
96
29
292
0.95
0.06
3.8
3.8
—
—
—
0
0
12
105
1.09
0.05
1.0
1.0
10.55
17.68
u/ml
—
7
73
10
105
0.91
0.04
1.0
1.1
—
—
—
0
0
33
328
0.96
0.04
4.3
3.8
—
—
—
0
0
11
114
0.92
0.04
1.1
1.1
—
—
—
0
0
18
178
0.97
0.00
1.2
1.3
37.48
8.85
u/ml
0.46
18
167
30
291
0.99
0.00
1.1
1.2
1.23
2.45
u/ml
0.50
14
163
64
613
1.00
0.00
1.3
1.3
—
—
—
0
0
104
997
1.00
0.00
15.0
13.5
0.92
1.24
%
4.58
104
990
36
342
1.01
0.00
1.1
1.1
—
—
—
0
0
13
122
1.02
0.00
1.1
1.1
28.03
30.96
iu/ml
0.11
13
122
17
167
0.97
0.00
1.1
1.3
—
—
u/ml
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
6
66
0.87
-0.00
1.7
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.8
—
1.49
—
0
8
0
7
0.00
-0.00
0.0
1.9
—
367.57
—
0
7
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
9
88
0.98
-0.00
4.0
2.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
8
79
0.97
-0.00
3.0
2.3
—
176.40
—
0
13
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
6
57
1.01
-0.00
1.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint E4_ENDODIS and mortality.

Females

Parameter HR [95% CI] p-value
E4_ENDODIS 2.214 [1.89, 2.6] < 0.001
Birth year 0.992 [0.98, 1.0] 0.06

During the follow-up period (1.1.1998 — 31.12.2019), 836 out of 14401 females with E4_ENDODIS died.

Males

Parameter HR [95% CI] p-value
E4_ENDODIS 2.624 [2.25, 3.06] < 0.001
Birth year 0.988 [0.98, 1.0] 0.011

During the follow-up period (1.1.1998 — 31.12.2019), 808 out of 12884 males with E4_ENDODIS died.

Mortality risk

Mortality risk for people of age

years, who have E4_ENDODIS.

N-year risk Females Males
1 0.208% 0.389%
5 1.229% 2.819%
10 2.919% 6.793%
15 5.687% 13.4%
20 9.654% 22.642%

Relationships between endpoints

↥

Index endpoint: E4_ENDODIS – Other endocrine disorders

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data